Purchase Order 75N95024P00616
Award Date
9/16/24
Potential Completion Date
10/16/24
Potential Value
$16K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Vector Biosystems, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Malvern, PA 19355, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned, self-certified small disadvantaged biotechnology company located in Malvern, Pennsylvania. The $6,230 firm-fixed-price contract was awarded on March 12, 2010 for the delivery of a KI vector constructed with interleukin-17A (IL-17A)....
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $18,728 firm fixed price purchase order to Vectorbuilder Inc. for the generation of an OCVAR8 stable cell line plasmid synthesis services. This contract does not have a set-aside designation, indicating that Vectorbuilder competed for the award in full and open competition. Vectorbuilder is a specialized biotechnology company that provides molecular...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...
Vector Biosystems, Inc., doing business as Vector Biolabs, has been awarded a firm fixed-price purchase order valued at three thousand six hundred twenty-five U.S. dollars ($3,625) by the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism (NIAAA). The contract term is from November 24, 2017 through November 23, 2018 for Vector Biolabs to provide unspecified products or services to NIAAA in support of its biomedical research programs. Place of performance will be...